Press Release Archive

Alphabetical (index by companies).
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Press Releases from InDex Pharmaceuticals: (7 total)

Press Releases as widget for your website

26.10.12 - InDex Pharmaceuticals

InDex Pharmaceuticals Granted Japanese Patent for Novel Treatment of Steroid-Resistant Inflammation

Stockholm, October 24, 2012 – InDex Pharmaceuticals today announced that it has been granted a Japanese patent by the Japan Patent Office (JPO). The patent provides protection for the use of Kappapr... mehr

20.06.12 - InDex Pharmaceuticals

Kappaproct Drastically Reduces the Need for Colectomy in Patients with Severe Ulcerative Colitis

- InDex Pharmaceuticals reports positive clinical data in peer-reviewed journal Inflammatory Bowel Diseases - Stockholm, June 19, 2012 – InDex Pharmaceuticals today announced the publication of pos... mehr

29.05.12 - InDex Pharmaceuticals

InDex Pharmaceuticals Appoints Stig Løkke Pedersen as Board Member

- Former Lundbeck Executive Brings Strong Commercial Experience and Extensive Pharmaceutical Industry Network - Stockholm, May 29, 2012 – InDex Pharmaceuticals today announced that Stig Løkke Pede... mehr

30.04.12 - InDex Pharmaceuticals

InDex Pharmaceuticals Granted US Patent for Novel Treatment of Steroid-Resistant Inflammation

Stockholm, April 26, 2012 – InDex Pharmaceuticals today announced that it has been granted a patent by the United States Patent and Trademark Office. The patent provides additional protection for th... mehr

12.04.12 - InDex Pharmaceuticals

InDex Pharmaceuticals Expands Management Team

- InDex Pharmaceuticals Names Pernilla Sandwall Head of Clinical Operations and Thomas Knittel Chief Medical Officer - Stockholm, April 11, 2012 – InDex Pharmaceuticals today announced two addition... mehr

21.03.12 - InDex Pharmaceuticals

InDex Pharmaceuticals Develops Companion Diagnostic Test for New Ulcerative Colitis Therapy

- Personalized treatment option for patients with refractory ulcerative colitis - Stockholm, March 20, 2012 - InDex Pharmaceuticals today announced the development of a companion diagnostic test for ... mehr

07.03.12 - InDex Pharmaceuticals

InDex Pharmaceuticals Starts Phase III COLLECT Study with Kappaproct®

-- TLR9 Agonist for the Treatment of Chronic, Active, Treatment-Refractory Ulcerative Colitis -- Stockholm, March 6, 2012 - InDex Pharmaceuticals today announced the start of the COLLECT trial, a Eur... mehr

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9